Medtronic achieves CE Mark approval for BrainSenseā„¢ Adaptive deep brain stimulation and Electrode Identifier, a groundbreaking advance in personalized, sensing-enabled care for people with Parkinson’s through innovative brain-computer interface technology

European approval introduces the world’s only closed-loop DBS system with real-time, self-adjusting brain stimulation for people with Parkinson’s disease GALWAY, Ireland, Jan. 13, 2025 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, announced today CE…